Cargando…

Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe

BACKGROUND: Sub-optimal adherence to antiretroviral therapy (ART) is reportedly worse amongst young people living with HIV (YPLHIV). Group adherence counselling can be useful to improve adherence. OBJECTIVES: We evaluated an enhanced adherence counselling group intervention (EACGI) amongst YPLHIV fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasimonje, Bahati, Shamu, Tinei, Mudzviti, Tinashe, Luethy, Ruedi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603063/
https://www.ncbi.nlm.nih.gov/pubmed/34858653
http://dx.doi.org/10.4102/sajhivmed.v22i1.1292
_version_ 1784601696449593344
author Kasimonje, Bahati
Shamu, Tinei
Mudzviti, Tinashe
Luethy, Ruedi
author_facet Kasimonje, Bahati
Shamu, Tinei
Mudzviti, Tinashe
Luethy, Ruedi
author_sort Kasimonje, Bahati
collection PubMed
description BACKGROUND: Sub-optimal adherence to antiretroviral therapy (ART) is reportedly worse amongst young people living with HIV (YPLHIV). Group adherence counselling can be useful to improve adherence. OBJECTIVES: We evaluated an enhanced adherence counselling group intervention (EACGI) amongst YPLHIV failing a non-nucleoside reverse transcriptase (NNRTI)-based first-line ART regimen. METHOD: This was a retrospective cohort study using routinely collected data of YPLHIV failing NNRTI-based first-line ART. Patients with confirmed virological failure were referred for EACGI, a 12-week curriculum of weekly, 1.5-h sessions accommodating 8–15 people per group. It aimed to facilitate readiness to switch to second-line ART and improve adherence through a mental health intervention. Viral loads of HIV were measured pre-EACGI; at baseline; 3, 6 and 12 months post switch. RESULTS: Fifty-seven patients aged 13–25 years were invited to EACGI and followed for up to 48 weeks. Thirty-three (58%) patients attended at least four sessions, whilst 24 (42%) attended none. Amongst those who attended none, two (8%) were transferred out, three (13%) were lost to follow-up and two (8%) had died by week 48 of follow-up, whilst all who attended were still in care. By week 48, amongst patients still in care, 29%, 44% and 67% of those who attended no sessions, 4–9 and 10–12 sessions, respectively, had viral loads of < 50 copies/mL. CONCLUSION: An EACGI is a promising intervention for YPLHIV failing ART prior to treatment switch, leading to improved adherence. This study’s findings support the need for further enquiry into rigorous, evidence-based multilevel adherence interventions that are acceptable and effective for YPLHIV.
format Online
Article
Text
id pubmed-8603063
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AOSIS
record_format MEDLINE/PubMed
spelling pubmed-86030632021-12-01 Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe Kasimonje, Bahati Shamu, Tinei Mudzviti, Tinashe Luethy, Ruedi South Afr J HIV Med Original Research BACKGROUND: Sub-optimal adherence to antiretroviral therapy (ART) is reportedly worse amongst young people living with HIV (YPLHIV). Group adherence counselling can be useful to improve adherence. OBJECTIVES: We evaluated an enhanced adherence counselling group intervention (EACGI) amongst YPLHIV failing a non-nucleoside reverse transcriptase (NNRTI)-based first-line ART regimen. METHOD: This was a retrospective cohort study using routinely collected data of YPLHIV failing NNRTI-based first-line ART. Patients with confirmed virological failure were referred for EACGI, a 12-week curriculum of weekly, 1.5-h sessions accommodating 8–15 people per group. It aimed to facilitate readiness to switch to second-line ART and improve adherence through a mental health intervention. Viral loads of HIV were measured pre-EACGI; at baseline; 3, 6 and 12 months post switch. RESULTS: Fifty-seven patients aged 13–25 years were invited to EACGI and followed for up to 48 weeks. Thirty-three (58%) patients attended at least four sessions, whilst 24 (42%) attended none. Amongst those who attended none, two (8%) were transferred out, three (13%) were lost to follow-up and two (8%) had died by week 48 of follow-up, whilst all who attended were still in care. By week 48, amongst patients still in care, 29%, 44% and 67% of those who attended no sessions, 4–9 and 10–12 sessions, respectively, had viral loads of < 50 copies/mL. CONCLUSION: An EACGI is a promising intervention for YPLHIV failing ART prior to treatment switch, leading to improved adherence. This study’s findings support the need for further enquiry into rigorous, evidence-based multilevel adherence interventions that are acceptable and effective for YPLHIV. AOSIS 2021-10-29 /pmc/articles/PMC8603063/ /pubmed/34858653 http://dx.doi.org/10.4102/sajhivmed.v22i1.1292 Text en © 2021. The Authors https://creativecommons.org/licenses/by/4.0/Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
spellingShingle Original Research
Kasimonje, Bahati
Shamu, Tinei
Mudzviti, Tinashe
Luethy, Ruedi
Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe
title Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe
title_full Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe
title_fullStr Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe
title_full_unstemmed Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe
title_short Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe
title_sort group counselling for adherence support among young people failing first-line antiretroviral therapy in zimbabwe
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603063/
https://www.ncbi.nlm.nih.gov/pubmed/34858653
http://dx.doi.org/10.4102/sajhivmed.v22i1.1292
work_keys_str_mv AT kasimonjebahati groupcounsellingforadherencesupportamongyoungpeoplefailingfirstlineantiretroviraltherapyinzimbabwe
AT shamutinei groupcounsellingforadherencesupportamongyoungpeoplefailingfirstlineantiretroviraltherapyinzimbabwe
AT mudzvititinashe groupcounsellingforadherencesupportamongyoungpeoplefailingfirstlineantiretroviraltherapyinzimbabwe
AT luethyruedi groupcounsellingforadherencesupportamongyoungpeoplefailingfirstlineantiretroviraltherapyinzimbabwe